Tacrolimus (FK506) versus cyclosporine microemulsion (Neoral) as maintenance immunosuppression therapy in kidney transplant recipients

Transplantation Proceedings

Volumn 37, Issue 7, 2005, Pages 3025-3028

  Abou Jaoude, M M ^a   Najm, R ^b   Shaheen, J ^a   Nawfal, N ^a   Abboud, S ^c   AlHabash, M ^d   Darwish, M ^e   Mulhem, A ^e   Ojjeh, A ^e   Almawi, W Y ^f  

^a Sacre Coeur Hospital Baabda   (Lebanon)

^b Neuroscience Department   (Canada)

^c Notre Dame De Secours ^*  (Lebanon)

^d Department of Gastroenterology   (Syrian Arab Republic)

^e Al Shami Hospital   (Syrian Arab Republic)

^f ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DACLIZUMAB; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTERIAL INFECTION; CHOLESTEROL BLOOD LEVEL; CHRONIC GLOMERULONEPHRITIS; CHRONIC PYELONEPHRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; DIALYSIS; DIET RESTRICTION; DISEASE SEVERITY; DONOR; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLISM; MICROEMULSION; MYCOSIS; PRIORITY JOURNAL; RECIPIENT; SENSITIZATION; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS INFECTION;

ADULT; CADAVER; CYCLOSPORINS; EMULSIONS; FASTING; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LIVING DONORS; MALE; TACROLIMUS; TISSUE DONORS;

EID: 26444564710     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.08.040     Document Type: Article

References (11)

1. W.Y. Almawi, O.K. Melemedjian Clinical and mechanistic differences between FK506 (tacrolimus) and cyclosporin A Nephrol Dial Transplant 15 2000 1916
2. G.A. Knoll, R.C. Bell Tacrolimus versus cyclosporin for immunosuppression in renal transplantation meta-analysis of randomised trials BMJ 318 1999 1104
3. C.C. Baan, C. van Riemsdijk, I.C. van Overbeeke Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression Clin Transplant 15 2001 276
4. A. Israni, S. Brozena, O. Pankewycz Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients Am J Kidney Dis 39 2002 E16
5. J. Reyes, A. Jain, G. Mazariegos Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection Transplantation 69 2000 2573
6. N. Selzner, F. Durand, J. Bernuau Conversion from cyclosporine to FK506 in adult liver transplant recipients a combined North American and European experience Transplantation 72 2001 1061
7. C. Blume, M. Hollenbeck, K. Ivens Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients Transplant Proc 33 2001 3161
8. J.M. Boots, E.M. van Duijnhoven, M.H. Christiaans Single- center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients Transpl Int 14 2001 370
9. M. Kohnle, U. Zimmermann, P. Lutkes Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia Transpl Int 13 suppl 1 2000 S345
10. A.D. Mayer, J. Dmitrewski, J.P. Squifflet Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection a report of the European Tacrolimus Multicenter Renal Study Group Transplantation 64 1997 436
11. J.D. Pirsch, J. Miller, M.H. Deierhoi FK506 Kidney Transplant Study Group A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation Transplantation 63 1997 977